Effect of the acyl-CoA:cholesterol acyltransferase inhibitor, E5324, on experimental atherosclerosis in rabbits
- 30 June 1994
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 107 (2), 187-201
- https://doi.org/10.1016/0021-9150(94)90020-5
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Comparison of CI-976, an ACAT inhibitor, and selected lipid-lowering agents for antiatherosclerotic activity in iliac-femoral and thoracic aortic lesions. A biochemical, morphological, and morphometric evaluation.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Antiatherosclerotic agents. A structurally novel bivalent inhibitor of AcylCoA:cholesterol O-acyltransferase with systemic activityJournal of Medicinal Chemistry, 1990
- Antiatherosclerotic and antihyperlipidemic effects of octimibate sodium in rabbitsAtherosclerosis, 1988
- Chlorpromazine inhibits arterial ACAT and reduces arterial cholesterol and cholesteryl ester accumulation in cholesterol-fed rabbits.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1986
- Role of acyl-CoA: cholesterol acyltransferase in cellular cholesterol metabolism.Journal of Lipid Research, 1985
- Reduced cholesterol transmucosal transport in rats with inhibited mucosal acyl CoA:cholesterol acyltransferase and normal pancreatic function.Journal of Lipid Research, 1984
- Role of acyl CoA:cholesterol acyltransferase in cholesterol absorption and its inhibition by 57-118 in the rabbit.Journal of Lipid Research, 1983
- The effect of N-(α-Methylbenzyl) linoleamide on experimental atherosclerosis in rabbitsJournal of Atherosclerosis Research, 1969
- Cholesterol Ester MetabolismPhysiological Reviews, 1965
- Changes in Lipid Composition of Lymph During Cholesterol Absorption in the RatAmerican Journal of Physiology-Legacy Content, 1957